{"name":"Curasight","slug":"curasight","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"64Cu-DOTA-AE105","genericName":"64Cu-DOTA-AE105","slug":"64cu-dota-ae105","indication":"Neuroendocrine tumors","status":"phase_2"}]}],"pipeline":[{"name":"64Cu-DOTA-AE105","genericName":"64Cu-DOTA-AE105","slug":"64cu-dota-ae105","phase":"phase_2","mechanism":"Somatostatin receptor targeting","indications":["Neuroendocrine tumors"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOWWFVRmZleU1TdzJjVjMzSWw2bjlISV9MQnA4Wjl0MTNuSkx2aHZpQm5xVzdkbDR1cDV2TGtCT1Y2MzZZOHpBVmE3YkFmNXMzOFh3S3pPRnNWLXFMZHR4SFRNLU9NX2xjN2VQYW9kaUc5S3pucFU5ZnpSX3VwdFd1dVlWMzJSX3pweEZmSGNtZG1NRUJrU2tYc2VUTEREVU5fOHo1UDZ3?oc=5","date":"2026-03-26","type":"pipeline","source":"Biostock","summary":"Curasight welcomes international radiopharma experts to the board - Biostock","headline":"Curasight welcomes international radiopharma experts to the board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOakVIdU1mMllWMGhlZnl0Vk1HMzNlTjV5YkJGc2JqRHd5Z2tka0ZoQjVSWHc4UHdPd2pkeWlpTlNWX3ZuNUROLUNDWV9GeDlybUpxTFU1WXlwdlp6anZpbTRldGZuQXVrS0E5VUpMdlpkNFZqYmpvQjVfRHp2NDV3eEJoYmoyXzBL?oc=5","date":"2026-02-16","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Curasight to present at TD Cowen's 46th Annual Health Care Conference in Boston - Yahoo Finance Singapore","headline":"Curasight to present at TD Cowen's 46th Annual Health Care Conference in Boston","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-03","type":"pipeline","source":"simplywall.st","summary":"Individual investors invested in Curasight A/S (NGM:CURAS) up 17% last week, insiders too were rewarded - simplywall.st","headline":"Individual investors invested in Curasight A/S (NGM:CURAS) up 17% last week, insiders too were rewarded","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQeFV1SkFMUXlpNUJxZEduYU1PMFZFbDMwb0hJSjVEWGlXOVVRaEdJVVJwbTFLMms1eG41R1Y5MDRTR2VoaXBwYm1nZ1h6MFA5S1FkZXI0bndLa3JrWTdxMTNUTGh2dktGNEVDODYxNmFKVUk2N25vZDY0eW9DZXhPM3luaUJ0OGE4NlUySXdR?oc=5","date":"2025-05-23","type":"pipeline","source":"Biostock","summary":"New positive results for Curasight in brain cancer - Biostock","headline":"New positive results for Curasight in brain cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPWkp0UmxKTmVfajVPQ3pMaFFmeUx6U1duUzVDQjdhbHZHZldKSUdZZEZfbVBZNnpuRHJQM1AyQU1td1Jhc29XSm1TQ1NTaEpKdTVzS2FYcUlPME1Nd0xhRVg5SEdLTk1zMEJCSm85cXNtOXluYXZGTWhIY09heFJEQTVPTENybW5VQWFPTzN6RQ?oc=5","date":"2024-10-22","type":"pipeline","source":"Biostock","summary":"Curasight well-placed in hot radiopharma sector - Biostock","headline":"Curasight well-placed in hot radiopharma sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1KRjVLdjZJdjFvb1hjOVd5Ml9VdWpnb1pROUczTmM0R1lmUmFLYXY0dE9kUkVfeFVrSkpJZ1liQWpwOGQxREY0dlpoclJYNkp0cW1UM3hnbkFMYTQ4MERNMnBvV3FVRlBhR2tQRU5tTzM?oc=5","date":"2023-11-24","type":"pipeline","source":"Biostock","summary":"The news sweep Friday 24 November - Biostock","headline":"The news sweep Friday 24 November","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}